De Mey J G, Defreyn G, Lenaers A, Calderon P, Roba J
J Cardiovasc Pharmacol. 1987 May;9(5):525-35. doi: 10.1097/00005344-198705000-00004.
We compared acute and chronic effects of atriopeptin III in normotensive and spontaneously hypertensive rats. Atriopeptin III relaxed isolated aortae and intrarenal microarteries but not coronary and mesenteric microarteries of normotensive rats. Effects on arterial smooth muscle were comparable in hypertensive and normotensive rats and were not affected by long-term treatment of the animals with the peptide. Acute administration of atriopeptin III (4-400 nmol/kg, intravenously) reduced systolic blood pressure in conscious spontaneously hypertensive and renal hypertensive rats but not in normotensive rats. In spontaneously hypertensive rats, nephrectomy increased the sensitivity to and the duration of the acute antihypertensive effect. Renal subcellular fractions rapidly inactivated atriopeptin III in vitro. This atriopeptinase activity was comparable for normotensive and spontaneously hypertensive rats and was not affected by long-term treatment of the rats with the peptide. Continuous administration of low doses of atriopeptin III (0.4 and 4.0 nmol/kg/h, intravenously (i.v.) during 7 days) caused a progressive reduction in systolic blood pressure in spontaneously hypertensive but not in normotensive rats. It did not affect plasma levels of aldosterone or renin and resulted in less than a doubling of the plasma levels of atrial natriuretic peptides. These findings confirm that atrial natriuretic peptides preferentially relax the renal microvasculature. They demonstrate that although atriopeptin III comparably relaxes arterial smooth muscle of normotensive and spontaneously hypertensive rats, both acute and chronic administration of the peptide preferentially lower blood pressure in hypertensive rats. Rather than contributing to the effects on blood pressure, the kidneys modulate the duration of action of atrial natriuretic peptides.
我们比较了心钠素III对正常血压大鼠和自发性高血压大鼠的急性和慢性影响。心钠素III可使正常血压大鼠的离体主动脉和肾内微动脉舒张,但对冠状动脉和肠系膜微动脉无此作用。高血压大鼠和正常血压大鼠对动脉平滑肌的影响相当,且该肽对动物的长期治疗并未影响这种作用。急性静脉注射心钠素III(4 - 400 nmol/kg)可使清醒的自发性高血压大鼠和肾性高血压大鼠的收缩压降低,但对正常血压大鼠无效。在自发性高血压大鼠中,肾切除可增加对急性降压作用的敏感性并延长其持续时间。肾亚细胞组分在体外可迅速使心钠素III失活。正常血压大鼠和自发性高血压大鼠的这种心钠素酶活性相当,且该肽对大鼠的长期治疗并未影响这种活性。连续7天静脉低剂量输注心钠素III(0.4和4.0 nmol/kg/h)可使自发性高血压大鼠的收缩压逐渐降低,但对正常血压大鼠无效。它不影响醛固酮或肾素的血浆水平,且导致心房利钠肽的血浆水平增加不到一倍。这些发现证实,心房利钠肽优先舒张肾微血管。它们表明,尽管心钠素III对正常血压大鼠和自发性高血压大鼠的动脉平滑肌舒张作用相当,但该肽的急性和慢性给药均优先降低高血压大鼠的血压。肾脏并非对血压影响起作用,而是调节心房利钠肽的作用持续时间。